Action Abivax (PK) - AAVXF

Abivax SA (PK) (AAVXF) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

80,03

( - )

Prix Achat

80,03

Prix Vente

80,03

Volume échangé

Volume moyen (3 m)

US$ 308 651

Volume financier

0,00 Fourchette du Jour 0,00

10,3248 Plage de 52 semaines 133,40

Cap du marché

6,386B

Valeur d'Entreprise

10,316B

Clôture Veille

80,03

Ouverture

Dernière Transaction

Dernière heure de transaction

VWAP

Chiffre d'affairess (LTM)

4,92M

Bénéfice net (LTM)

-332,2M

Actions en circulation

79 800 669

Flottant (%)

60,69%

Détention Institutionnelle (%)

132,72%

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-29,84

Ratio Cours/Ventes (P/S)

2,19k

Bénéfice par action (BPA)

-4,52

Bêta

-0,21

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical devel... ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn’s disease. The company was incorporated in 2013 and is headquartered in Paris, France. Show more

Secteur

Healthcare

Industrie

Biotechnology & Life Sciences

Site Web

www.abivax.com

Siège social

Paris, France

Fondé

2026

Abivax SA (PK) est coté dans le secteur Healthcare de la OTC Markets avec le ticker AAVXF. Le dernier cours de clôture d'Abivax (PK) était de US$80,03. Au cours de la dernière année, les actions de Abivax (PK) ont été négociées dans une fourchette de prix de US$ 10,3248 à US$ 133,40.

Abivax (PK) compte actuellement 79 800 669 actions en circulation. La capitalisation boursière d'Abivax (PK) est de US$6,39 milliard. Abivax (PK) a un ratio cours/bénéfice (ratio PE) de -29.84.

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	-10.42	-11.5201768933	90.45	90.45	80.03	500	80.03	CS
12	-35.62	-30.7998270644	115.65	126	71.26	217	86.86081892	CS
26	-39.07	-32.8043660789	119.1	128.4	71.26	223	105.72934335	CS
52	69.48	658.578199052	10.55	133.4	10.3248	2746	78.74501619	CS
156	60.03	300.15	20	133.4	5.81	2302	70.36491213	CS
260	44.93	128.005698006	35.1	133.4	5.79	1792	62.21177685	CS

AAVXF - Frequently Asked Questions (FAQ)

What is the current Abivax SA (PK) share price?

The current share price of Abivax SA (PK) is US$ 80,03

How many Abivax SA (PK) shares are in issue?

Abivax SA (PK) has 79 800 669 shares in issue

What is the market cap of Abivax SA (PK)?

The market capitalisation of Abivax SA (PK) is USD 6,39B

What is the 1 year trading range for Abivax SA (PK) share price?

Abivax SA (PK) has traded in the range of US$ 10,3248 to US$ 133,40 during the past year

What is the PE ratio of Abivax SA (PK)?

The price to earnings ratio of Abivax SA (PK) is -29,84

What is the cash to sales ratio of Abivax SA (PK)?

The cash to sales ratio of Abivax SA (PK) is 2,19k

What is the registered address of Abivax SA (PK)?

The registered address for Abivax SA (PK) is 7-11 Boulevard Haussmann, Paris, Ile-de-France, 75009

What is the Abivax SA (PK) website address?

The website address for Abivax SA (PK) is www.abivax.com

Which industry sector does Abivax SA (PK) operate in?

Abivax SA (PK) operates in the Biotechnology & Life Sciences sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Abivax SA (PK) (AAVXF)

Abivax SA (PK) (AAVXF) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Abivax SA (PK)

AAVXF Dernières nouvelles

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B5 - Prospectus [Rule 424(b)(5)]

AAVXF - Frequently Asked Questions (FAQ)

AAVXF Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités